Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:38:09.372Z.
Calculation as of: 2026-10-06T19:38:09.372Z.
Quote observation: 2026-10-06T19:35:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8b72fc44080d8c671fb5883057af471201fb64a542d8aebba0fac2689ec384f4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Sunshine Biopharma, Inc.
Market Cap
$868323.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$850879.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$894080.00
EV/EBITDA Ratio
N/A
TTM Avg
1464.50x
3Y Avg
6462.34x
5Y Avg
6462.34x
Market Cap
$827771.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$835190.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$814420.00
EV/EBITDA Ratio
N/A
TTM Avg
21.16x
3Y Avg
12.50x
5Y Avg
7.56x
Market Cap
$747565.00
EV/EBITDA Ratio
N/A
TTM Avg
1997208.30x
3Y Avg
2574392.09x
5Y Avg
2574392.09x
Market Cap
$1.02M
EV/EBITDA Ratio
N/A
TTM Avg
1.21x
3Y Avg
1.21x
5Y Avg
1.21x
Market Cap
$695428.00
EV/EBITDA Ratio
4.13x
TTM Avg
10.27x
3Y Avg
9.51x
5Y Avg
9.51x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sunshine Biopharma, Inc. (SBFM) | $868323.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $850879.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $894080.00 | N/A | 1464.50x | 6462.34x | 6462.34x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827771.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $835190.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $814420.00 | N/A | 21.16x | 12.50x | 7.56x |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $747565.00 | N/A | 1997208.30x | 2574392.09x | 2574392.09x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A | 1.21x | 1.21x | 1.21x |
| CDT Equity Inc. (CDT)vs › | $695428.00 | 4.13x | 10.27x | 9.51x | 9.51x |
| Clearmind Medicine Inc. (CMND)vs › | $1.09M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
